NCT04270968

Shock Wave Therapy On Cervical Pain Following Neck Dissection Surgery

Efficacy of Extracorporeal Shock Wave Therapy (ESWT) on Cervical Myofascial Pain Following Neck Dissection Surgery

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 46 (actual)
• Sponsor: Qassim University · Academic / Other
• Sex: All
• Age: 35 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

Myofascial pain syndrome (MPS) is a musculoskeletal disorder which is characterized by pain, muscle spasms and muscle tenderness, as well as a limited range of motion, weakness, and rarely, autonomous dysfunction.

Detailed description

The occurrences of morbidity of the neck after cancer therapy were considerable and consisted of neck pain, loss of sensation, and decreased range of motion. Extracorporeal shock wave therapy (ESWT) is one of the treatment options used for patients with myofascial pain syndrome through elimination of ischemia and modulation of vasoneuroactive substance (two major causes of trigger pathophysiology) and mechanical transduction as a cellular response to external stimulation. the aim of this study was to investigate efficacy of extracorporeal shock wave therapy (ESWT) on cervical myofascial pain following neck dissection surgery.

Conditions

• Pain
• Cervical Pain

Interventions

Type	Name	Description
DEVICE	extra-corporeal shock wave therapy	Extracorporeal Shock Wave Therapy (ESWT) has been introduced efficiently for more than twenty years as a treatment modality in orthopedic and musculoskeletal disorders. ESWT has mechanical and cellular impacts on tissues regeneration and pain management through cavitation bubbles, acoustic micro streaming, and hyper-vascularity that can directly affect tissue calcifications, and modulate cell activity.
DRUG	topical none steroidal anti-inflammatory drug	participants received 1% topical diclofenac gel on the tender points 3 times /day for 4 weeks.

Timeline

• Start date: 2018-11-03
• Primary completion: 2019-11-20
• Completion: 2019-12-03
• First posted: 2020-02-17
• Last updated: 2020-02-17

Locations

1 site across 1 country: Egypt

Regulatory

• FDA-regulated device study